'Chinese Peptides' Are the Latest Biohacking Trend in the Tech World
An investigation into the gray-market peptide trend spreading through Silicon Valley's tech and startup scene, where compounds including BPC-157, TB-500, and thymosin alpha-1 are sourced directly from Chinese manufacturers outside FDA oversight. The piece traces the trend from private parties and 'hacker houses' to organized 'peptide raves,' and examines the regulatory gray zone these products occupy as imports of hormone and peptide compounds from China roughly doubled year over year.
This is a summary. The reporting is The New York Times's, and the link below goes to the original article.